Literature DB >> 17443334

The dentate nucleus in Friedreich's ataxia: the role of iron-responsive proteins.

Arnulf H Koeppen1, Susan C Michael, Mitchell D Knutson, David J Haile, Jiang Qian, Sonia Levi, Paolo Santambrogio, Michael D Garrick, Jacques B Lamarche.   

Abstract

Frataxin deficiency in Friedreich's ataxia (FRDA) causes cardiac, endocrine, and nervous system manifestations. Frataxin is a mitochondrial protein, and adequate amounts are essential for cellular iron homeostasis. The main histological lesion in the brain of FRDA patients is neuronal atrophy and a peculiar proliferation of synaptic terminals in the dentate nucleus termed grumose degeneration. This cerebellar nucleus may be especially susceptible to FRDA because it contains abundant iron. We examined total iron and selected iron-responsive proteins in the dentate nucleus of nine patients with FRDA and nine normal controls by biochemical and microscopic techniques. Total iron (1.53 +/- 0.53 mumol/g wet weight) and ferritin (206.9 +/- 46.6 mug/g wet weight) in FRDA did not significantly differ from normal controls (iron: 1.78 +/- 0.88 mumol/g; ferritin: 210.9 +/- 9.0 mug/g) but Western blots exhibited a shift to light ferritin subunits. Immunocytochemistry of the dentate nucleus revealed loss of juxtaneuronal ferritin-containing oligodendroglia and prominent ferritin immunoreactivity in microglia and astrocytes. Mitochondrial ferritin was not detectable by immunocytochemistry. Stains for the divalent metal transporter 1 confirmed neuronal loss while endothelial cells reacting with antibodies to transferrin receptor 1 protein showed crowding of blood vessels due to collapse of the normal neuropil. Regions of grumose degeneration were strongly reactive for ferroportin. Purkinje cell bodies, their dendrites and axons, were also ferroportin-positive, and it is likely that grumose degeneration is the morphological manifestation of mitochondrial iron dysmetabolism in the terminals of corticonuclear fibers. Neuronal loss in the dentate nucleus is the likely result of trans-synaptic degeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17443334     DOI: 10.1007/s00401-007-0220-y

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  65 in total

Review 1.  Mitochondrial metals as a potential therapeutic target in neurodegeneration.

Authors:  A Grubman; A R White; J R Liddell
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

2.  Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.

Authors:  Mariana Igoillo-Esteve; Ana F Oliveira; Cristina Cosentino; Federica Fantuzzi; Céline Demarez; Sanna Toivonen; Amélie Hu; Satyan Chintawar; Miguel Lopes; Nathalie Pachera; Ying Cai; Baroj Abdulkarim; Myriam Rai; Lorella Marselli; Piero Marchetti; Mohammad Tariq; Jean-Christophe Jonas; Marina Boscolo; Massimo Pandolfo; Décio L Eizirik; Miriam Cnop
Journal:  JCI Insight       Date:  2020-01-30

Review 3.  Friedreich's ataxia: pathology, pathogenesis, and molecular genetics.

Authors:  Arnulf H Koeppen
Journal:  J Neurol Sci       Date:  2011-04-15       Impact factor: 3.181

Review 4.  Dentate Update: Imaging Features of Entities That Affect the Dentate Nucleus.

Authors:  K M Bond; W Brinjikji; L J Eckel; D F Kallmes; R J McDonald; C M Carr
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

5.  Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia.

Authors:  Maria R Stefanescu; Moritz Dohnalek; Stefan Maderwald; Markus Thürling; Martina Minnerop; Andreas Beck; Marc Schlamann; Joern Diedrichsen; Mark E Ladd; Dagmar Timmann
Journal:  Brain       Date:  2015-03-28       Impact factor: 13.501

6.  Reply: To PMID 23328073.

Authors:  L Vedolin
Journal:  AJNR Am J Neuroradiol       Date:  2013-02       Impact factor: 3.825

7.  The neuropathology of late-onset Friedreich's ataxia.

Authors:  Arnulf H Koeppen; Jennifer A Morral; Rodney D McComb; Paul J Feustel
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

8.  Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration.

Authors:  Kuchuan Chen; Guang Lin; Nele A Haelterman; Tammy Szu-Yu Ho; Tongchao Li; Zhihong Li; Lita Duraine; Brett H Graham; Manish Jaiswal; Shinya Yamamoto; Matthew N Rasband; Hugo J Bellen
Journal:  Elife       Date:  2016-06-25       Impact factor: 8.140

Review 9.  Friedreich ataxia: neuropathology revised.

Authors:  Arnulf H Koeppen; Joseph E Mazurkiewicz
Journal:  J Neuropathol Exp Neurol       Date:  2013-02       Impact factor: 3.685

10.  Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model.

Authors:  Yuxi Shan; Robert A Schoenfeld; Genki Hayashi; Eleonora Napoli; Tasuku Akiyama; Mirela Iodi Carstens; Earl E Carstens; Mark A Pook; Gino A Cortopassi
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.